CRYSTAL study shows good results of personalized anti-VEGF treatment regimen in CRVO

Two-year results of the CRYSTAL study show that an as-needed medication regimen with frequent monitoring can reduce the number of anti-VEGF injections needed to achieve and maintain good anatomic and visual acuity outcomes in central retinal vein occlusion.According to Michael Larsen, MD, DMSc, member of the CRYSTAL Study Group, “The criteria of the CRYSTAL regimen can be easily transferred into clinical practice.”